Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 124393
Published online Jan 14, 2027. doi: 10.3748/wjg.124393
Published online Jan 14, 2027. doi: 10.3748/wjg.124393
Figure 6 Summary of molecular features and pathway activities in the patient with colon cancer.
A: Tumor mutation burden, microsatellite instability status, and immune-microenvironment features; B: Relative expression (Z scores) of selected genes; C: Kyoto Encyclopedia of Genes and Genomes pathway single sample gene set enrichment analysis; D: Hallmark pathway single sample gene set enrichment analysis. ssGSEA: Single sample gene set enrichment analysis.
- Citation: Chen YF, Huang C, Chen ZJ, Wang ZH. Significant response to tislelizumab plus bevacizumab in a patient with microsatellite instability-high colon cancer: A case report and review of literature. World J Gastroenterol 2027; 33(2): 124393
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/124393.htm
- DOI: https://dx.doi.org/10.3748/wjg.124393